Cullinan Therapeutics Inc (CGEM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -90,355 | -58,141 | 109,195 | 136,283 | 161,173 |
| Depreciation Amortization | 153 | 72 | 93 | 34 | 25 |
| Accounts payable and accrued liabilities | -169 | -630 | -509 | -1,654 | -70 |
| Other Working Capital | -3,468 | 1,180 | 11,176 | 16,187 | 51,101 |
| Other Operating Activity | 11,836 | 6,522 | -246,619 | -252,531 | -259,557 |
| Operating Cash Flow | $-82,003 | $-50,997 | $-126,664 | $-101,681 | $-47,328 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -208 | -159 | -1,042 | -251 | N/A |
| Net Acquisitions | N/A | N/A | 275,000 | 275,000 | 270,000 |
| Purchase Of Investment | -170,592 | -89,139 | -377,916 | -217,497 | -93,370 |
| Sale Of Investment | 198,094 | 104,482 | 352,933 | 220,333 | 158,933 |
| Investing Cash Flow | $27,294 | $15,184 | $248,975 | $277,585 | $335,563 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,825 | 1,825 | 2,375 | 2,200 | 2,200 |
| Common Stock Issued | 38,566 | -36 | 6,020 | 5,826 | 4,401 |
| Other Financing Activity | 0 | 0 | -34,328 | -1,047 | -1,047 |
| Financing Cash Flow | $40,391 | $1,789 | $-25,933 | $6,979 | $5,554 |
| Beginning Cash Position | 156,152 | 156,152 | 59,774 | 59,774 | 59,774 |
| End Cash Position | 141,834 | 122,128 | 156,152 | 242,657 | 353,563 |
| Net Cash Flow | $-14,318 | $-34,024 | $96,378 | $182,883 | $293,789 |
| Free Cash Flow | |||||
| Operating Cash Flow | -82,003 | -50,997 | -126,664 | -101,681 | -47,328 |
| Capital Expenditure | -208 | -159 | -1,133 | -251 | 0 |
| Free Cash Flow | -82,211 | -51,156 | -127,797 | -101,932 | -47,328 |